Completed

NCT Number: NCT01027624

Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia

This is a multi-centre survey of patients who are currently on lipid lowering pharmacological treatment in South Africa.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Undertreatment of Hypercholesterolaemia

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site

Johannesburg, South Africa

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subject must be 18 years of age or older of either gender or race.
Subject must provide informed consent and comply with the survey procedures.
Subject is on lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.

Exclusion criteria

Subjects who are unwilling or unable to provide informed consent.

Treatment and study plan

Primary outcomes

Proportion of patients on lipid-lowering pharmacological treatment reaching LDL-C goals according to NCEP ATP III/Updated 2004 NCEP ATP III

Secondary outcomes

Proportion of patients on lipid-lowering pharmacological treatment reaching LDL-C goals according to NCEP ATP III/Updated 2004 NCEP ATP III
Proportion of patients on lipid-lowering pharmacological treatment reaching LDL-C goals according to the Fourth Joint European Task Force Guidelines/South African Guidelines in primary/secondary prevention patients, patients with metabolic syndrome
Proportion of patients on lipid-lowering pharmacological treatment reaching the non HDL-C goals according to NCEP ATP III/Updated 2004 NCEP ATP III Guidelines

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia.

Acronym: CEPHEUS

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Dec 8, 2009
Registry last updated: Apr 15, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.